BR9205961A - Composição farmacêutica para a prevenção e/ou tratamento de processos patológicos, processo de usar uma heparina de baixo peso molecular para a preparação de uma composição farmacêutica e processo de tratar uma pessoa que sofre de um processo patológico - Google Patents
Composição farmacêutica para a prevenção e/ou tratamento de processos patológicos, processo de usar uma heparina de baixo peso molecular para a preparação de uma composição farmacêutica e processo de tratar uma pessoa que sofre de um processo patológicoInfo
- Publication number
- BR9205961A BR9205961A BR9205961A BR9205961A BR9205961A BR 9205961 A BR9205961 A BR 9205961A BR 9205961 A BR9205961 A BR 9205961A BR 9205961 A BR9205961 A BR 9205961A BR 9205961 A BR9205961 A BR 9205961A
- Authority
- BR
- Brazil
- Prior art keywords
- pharmaceutical composition
- pathological
- prevention
- molecular weight
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7016—Disaccharides, e.g. lactose, lactulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7024—Esters of saccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/727—Heparin; Heparan
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Diabetes (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Vascular Medicine (AREA)
- Oncology (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Auxiliary Devices For And Details Of Packaging Control (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL9802891A IL98028A (en) | 1991-05-02 | 1991-05-02 | Pharmaceuticals containing low molecular weight heparin (HWML) |
IL98298A IL98298A0 (en) | 1991-05-28 | 1991-05-28 | Pharmaceutical compositions comprising a heparin derivative |
PCT/US1992/003626 WO1992019249A1 (en) | 1991-05-02 | 1992-05-01 | Compositions for the prevention and/or treatment of pathological processes |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9205961A true BR9205961A (pt) | 1994-07-26 |
Family
ID=26322260
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9205961A BR9205961A (pt) | 1991-05-02 | 1992-05-01 | Composição farmacêutica para a prevenção e/ou tratamento de processos patológicos, processo de usar uma heparina de baixo peso molecular para a preparação de uma composição farmacêutica e processo de tratar uma pessoa que sofre de um processo patológico |
Country Status (15)
Country | Link |
---|---|
US (3) | US5474987A (pt) |
EP (1) | EP0583360B1 (pt) |
JP (1) | JPH06507635A (pt) |
KR (1) | KR100235782B1 (pt) |
AT (1) | ATE217796T1 (pt) |
AU (1) | AU668865B2 (pt) |
BR (1) | BR9205961A (pt) |
CA (1) | CA2102207A1 (pt) |
CZ (1) | CZ232593A3 (pt) |
DE (1) | DE69232615T2 (pt) |
FI (1) | FI934849A (pt) |
HU (1) | HUT67136A (pt) |
NO (1) | NO933942L (pt) |
SK (1) | SK120193A3 (pt) |
WO (1) | WO1992019249A1 (pt) |
Families Citing this family (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5605938A (en) | 1991-05-31 | 1997-02-25 | Gliatech, Inc. | Methods and compositions for inhibition of cell invasion and fibrosis using dextran sulfate |
US6750207B1 (en) * | 1992-05-01 | 2004-06-15 | Yeda Research And Development Co. Ltd. | Compositions for the regulation of cytokine activity |
AU686581B2 (en) * | 1992-11-10 | 1998-02-12 | Yeda Research And Development Co. Ltd. | Compositions for the regulation of cytokine activity |
AU6204594A (en) * | 1993-02-22 | 1994-09-14 | Ulrich-Christoph Von Arnim | Use of heparins for the treatment of inflammatory or immunological diseases |
US5980865A (en) * | 1995-08-18 | 1999-11-09 | Baker Norton Pharmaceuticals, Inc. | Method for treating late phase allergic reactions and inflammatory diseases |
CA2235223A1 (en) | 1995-10-30 | 1997-05-09 | Massachusetts Institute Of Technology | Rationally designed polysaccharide lyases derived from heparinase i |
IL129877A (en) * | 1996-11-27 | 2004-08-31 | Aventis Pharm Prod Inc | A pharmaceutical preparation containing a component having an Xa antagonist activity and an antifouling agent |
CN1287852C (zh) * | 1997-07-14 | 2006-12-06 | 村松乔 | 含有midkine或其抑制剂作为活性成分的药剂 |
CA2341412A1 (en) | 1998-08-27 | 2000-03-09 | Massachusetts Institute Of Technology | Rationally designed heparinases derived from heparinase i and ii |
US7056504B1 (en) | 1998-08-27 | 2006-06-06 | Massachusetts Institute Of Technology | Rationally designed heparinases derived from heparinase I and II |
IL127851A0 (en) * | 1998-12-30 | 1999-10-28 | Applied Research Systems | Inhibition of TNF activity |
US6597996B1 (en) * | 1999-04-23 | 2003-07-22 | Massachusetts Institute Of Technology | Method for indentifying or characterizing properties of polymeric units |
BR0012202A (pt) * | 1999-06-30 | 2002-04-02 | Hamilton Civic Hospitals Res | Composições de heparina de peso molecular médio (mmwh), método de tratamento de uma condição trombótica, método de prevenção da formação de um trombo, método de inibição da formação de trombos, composição farmacêutica, método de tratamento de trombose venosa profunda, método de prevenção de embolia pulmonar, método de preparação e usos de uma composição de mmwh |
AU4351201A (en) * | 2000-03-08 | 2001-09-17 | Massachusetts Inst Technology | Heparinase iii and uses thereof |
AU2001291549A1 (en) * | 2000-09-08 | 2002-03-22 | Hamilton Civic Hospitals Research Development Inc. | Antithrombotic compositions |
ES2324701T3 (es) * | 2000-09-12 | 2009-08-13 | Massachusetts Institute Of Technology | Metodos y productos relacionados con heparina de peso molecular bajo. |
WO2002032406A2 (en) | 2000-10-18 | 2002-04-25 | Massachusetts Institute Of Technology | Methods and products related to pulmonary delivery of polysaccharides |
CA2431709A1 (en) * | 2000-12-16 | 2002-06-20 | Aventis Pharma Deutschland Gmbh | Use of low molecular heparin for treating osteoarthritis |
EP1406571A4 (en) * | 2001-06-25 | 2007-05-30 | Depuy Int Ltd | LIPOSOMAL ENCAPSULATION OF GLYCOSAMINOGLYCANS FOR THE TREATMENT OF ARTHROSIS JOINTS |
WO2003011119A2 (en) * | 2001-07-31 | 2003-02-13 | Reddy Us Therapeutics, Inc. | Methods and compositions for diagnosis and treatment of vascular conditions |
EP1420820A4 (en) * | 2001-07-31 | 2005-04-06 | Univ Texas | ANTIGENS AND ANTIBODIES FOR TRANSLOQUED MOLECULES OF MICROORGANISMS AND USES THEREOF |
US7285536B2 (en) * | 2001-12-05 | 2007-10-23 | Yeda Research And Development Co., Ltd. | Anti-cancer therapeutic compounds |
US20040072796A1 (en) * | 2002-04-18 | 2004-04-15 | Embury Stephen H. | Method and composition for preventing pain in sickle cell patients |
US8071569B2 (en) * | 2002-09-20 | 2011-12-06 | Mousa Shaker A | Oxidized heparin fractions and their use in inhibiting angiogenesis |
WO2004067704A2 (en) | 2003-01-30 | 2004-08-12 | Prochon Biotech Ltd. | Freeze-dried fibrin matrices and methods for preparation thereof |
WO2005054493A2 (en) * | 2003-06-12 | 2005-06-16 | Mayo Foundation For Medical Education And Research | Altered activity of toll-like receptors |
JP4950660B2 (ja) | 2003-06-27 | 2012-06-13 | エチコン、インコーポレイテッド | 分娩後由来細胞を使用する眼組織の修復および再生 |
US9572840B2 (en) | 2003-06-27 | 2017-02-21 | DePuy Synthes Products, Inc. | Regeneration and repair of neural tissue using postpartum-derived cells |
WO2005032483A2 (en) * | 2003-10-01 | 2005-04-14 | Momenta Pharmaceuticals, Inc. | Polysaccharides for pulmonary delivery of active agents |
CN1819833A (zh) * | 2004-03-29 | 2006-08-16 | 克霖固鲁制药股份有限公司 | 促进hgf产生的含肝素类寡糖的药剂 |
US8450297B2 (en) * | 2004-08-16 | 2013-05-28 | Massachusetts Institute Of Technology | Rapid two-step synthesis of anti-coagulants |
PL1831356T3 (pl) | 2004-12-23 | 2017-07-31 | DePuy Synthes Products, Inc. | Komórki poporodowe pochodzące z tkanki pępowinowej i sposoby ich wytwarzania i stosowania |
MX2008000974A (es) * | 2005-07-22 | 2008-03-27 | Univ California | Composiciones de heparina e inhibicion de selectina. |
AU2006292224B2 (en) | 2005-09-19 | 2013-08-01 | Histogenics Corporation | Cell-support matrix and a method for preparation thereof |
AU2009250803A1 (en) * | 2008-05-20 | 2009-11-26 | Crystal Clear Partnership | Separation of polysaccharides by charge density gradient |
US10077420B2 (en) | 2014-12-02 | 2018-09-18 | Histogenics Corporation | Cell and tissue culture container |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL61201A (en) * | 1979-10-05 | 1984-09-30 | Choay Sa | Oligosaccharides having no more than 8 saccharide moieties,their obtention from heparin and pharmaceutical compositions containing them |
US4281108A (en) * | 1980-01-28 | 1981-07-28 | Hepar Industries, Inc. | Process for obtaining low molecular weight heparins endowed with elevated pharmacological properties, and product so obtained |
EP0114589B1 (en) * | 1982-12-20 | 1987-09-23 | The President And Fellows Of Harvard College | Inhibition of angiogenesis |
US4916219A (en) * | 1985-03-28 | 1990-04-10 | University Of Iowa Research Foundation | Oligosaccharide heparin fragments as inhibitors of complement cascade |
IT1214609B (it) * | 1985-05-17 | 1990-01-18 | Opocrin Spa | Esosaminoglicani solfati depolimerizzati ad attivita'antitrombotica, fibrinolitica, antinfiammatoria, loro procedimento di preparazione e composizioni farmaceutiche che li contengono. |
US4889808A (en) * | 1985-10-01 | 1989-12-26 | American Home Products | Method of enchancing t-PA and SCU-PA production |
EP0240098A3 (en) * | 1986-04-04 | 1989-05-10 | Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo | Oligo and polysaccharides for the treatment of diseases caused by retroviruses |
US4788307A (en) * | 1986-04-30 | 1988-11-29 | Choay S.A. | Oligosaccharidic fractions devoid or practically devoid of antithrombotic activity |
EP0245813B2 (en) * | 1986-05-16 | 2000-03-22 | ITALFARMACO S.p.A. | EDTA-free heparins, heparin fractions and fragments, processes for their preparation and pharmaceutical compositions containing them |
WO1988000017A1 (en) * | 1986-06-27 | 1988-01-14 | Boon Corporation Pty. Ltd. | Mat |
IL85145A (en) * | 1987-01-23 | 1994-08-26 | Univ Australian | Anti-metastatic pharmacological or veterinary preparations containing modified herpin with reduced anticoagulant activity |
FR2614026B1 (fr) * | 1987-04-16 | 1992-04-17 | Sanofi Sa | Heparines de bas poids moleculaire, a structure reguliere, leur preparation et leurs applications biologiques |
SE8702254D0 (sv) * | 1987-05-29 | 1987-05-29 | Kabivitrum Ab | Novel heparin derivatives |
WO1990003791A1 (en) * | 1988-10-05 | 1990-04-19 | Nicola Diferrante | Methods for interfering with hiv multiplication and composition for the treatment of aids |
IL88554A0 (en) * | 1988-12-01 | 1989-07-31 | Hadassah Med Org | Compositions containing a compound binding to a heparin receptor |
PT93847A (pt) * | 1989-04-24 | 1990-11-20 | Harvard College | Processo para a preparacao de oligossacaridos de baixo peso molecular derivados de heparina ou de sulfato de heparano despolimerizados e de composicoes farmaceuticas que os contem |
AT500533B8 (de) * | 2000-04-13 | 2007-02-15 | Man Nutzfahrzeuge Ag | Gas- oder trolleybus |
-
1992
- 1992-05-01 CZ CS932325A patent/CZ232593A3/cs unknown
- 1992-05-01 AT AT92911373T patent/ATE217796T1/de not_active IP Right Cessation
- 1992-05-01 JP JP4511483A patent/JPH06507635A/ja active Pending
- 1992-05-01 KR KR1019930703303A patent/KR100235782B1/ko not_active IP Right Cessation
- 1992-05-01 DE DE69232615T patent/DE69232615T2/de not_active Expired - Lifetime
- 1992-05-01 EP EP92911373A patent/EP0583360B1/en not_active Expired - Lifetime
- 1992-05-01 BR BR9205961A patent/BR9205961A/pt not_active Application Discontinuation
- 1992-05-01 WO PCT/US1992/003626 patent/WO1992019249A1/en active IP Right Grant
- 1992-05-01 HU HU9303110A patent/HUT67136A/hu unknown
- 1992-05-01 AU AU19131/92A patent/AU668865B2/en not_active Ceased
- 1992-05-01 SK SK1201-93A patent/SK120193A3/sk unknown
- 1992-05-01 CA CA002102207A patent/CA2102207A1/en not_active Abandoned
-
1993
- 1993-11-01 NO NO933942A patent/NO933942L/no unknown
- 1993-11-02 FI FI934849A patent/FI934849A/fi not_active Application Discontinuation
-
1995
- 1995-02-03 US US08/384,203 patent/US5474987A/en not_active Expired - Lifetime
- 1995-06-01 US US08/457,655 patent/US5686431A/en not_active Expired - Lifetime
-
1997
- 1997-11-07 US US08/966,315 patent/US5908837A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
CZ232593A3 (en) | 1994-07-13 |
EP0583360B1 (en) | 2002-05-22 |
NO933942L (no) | 1993-12-14 |
US5686431A (en) | 1997-11-11 |
NO933942D0 (no) | 1993-11-01 |
EP0583360A4 (pt) | 1994-04-06 |
AU1913192A (en) | 1992-12-21 |
DE69232615T2 (de) | 2003-01-30 |
ATE217796T1 (de) | 2002-06-15 |
JPH06507635A (ja) | 1994-09-01 |
WO1992019249A1 (en) | 1992-11-12 |
HUT67136A (en) | 1995-02-28 |
DE69232615D1 (de) | 2002-06-27 |
US5908837A (en) | 1999-06-01 |
EP0583360A1 (en) | 1994-02-23 |
CA2102207A1 (en) | 1992-11-03 |
HU9303110D0 (en) | 1994-01-28 |
FI934849A0 (fi) | 1993-11-02 |
US5474987A (en) | 1995-12-12 |
AU668865B2 (en) | 1996-05-23 |
FI934849A (fi) | 1993-12-31 |
SK120193A3 (en) | 1994-07-06 |
KR100235782B1 (ko) | 1999-12-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9205961A (pt) | Composição farmacêutica para a prevenção e/ou tratamento de processos patológicos, processo de usar uma heparina de baixo peso molecular para a preparação de uma composição farmacêutica e processo de tratar uma pessoa que sofre de um processo patológico | |
ES2192667T3 (es) | Tratamiento de los trastornos de la artritis, artritis reumatica y manifestaciones asociadas con los trastornos reumaticos. | |
DK0781278T3 (da) | Nye benzothiepiner, som har aktivitet som inhibitorer af ileal galdsyretransport og taurocholatoptagelse | |
KR920702220A (ko) | 산화적 손상에 관련된 질병을 억제하기 위한 방법 및 그 조성물 | |
PT977564E (pt) | Forscolina para promocao da massa corporal magra | |
DE69533112T2 (de) | Verwendung von flavolignanen zur herstellung von medikamenten mit antiproliferativer aktivität in gebärmutter,brust,eierstöcken | |
JO2373B1 (en) | W-carboxy-aryl diphenyl urease substitutes used as RAV inhibitors | |
DE69725860D1 (de) | PLAN ZUR VERABREICHUNG VON H+, K+-ATPase INHIBITOREN | |
DE69033970T2 (de) | Huperzin a analoge verbindungen | |
ATE170399T1 (de) | Zusammensetzung und verfahren zur behandlung viraler infektionen | |
Langeland | Effects of oestradiol-17β benzoate treatment on fracture healing and bone collagen synthesis in female rats | |
EE9900044A (et) | Farmatseutilised tooted veresoonte endoteelirakkude kahjustuste tagajärjel tekkinud haiguste raviks ja vältimiseks | |
ATE201601T1 (de) | Pharmazeutische zusammensetzungen enthaltend ein neutralisiertes virus, und verwendung derselben | |
Mateo-Casas et al. | Severe lymphopenia after subcutaneous cladribine in a patient with multiple sclerosis: To vaccinate or not? | |
WO2015023147A1 (ko) | mTOR/STAT3 신호억제제 처리된 면역조절능을 갖는 간엽 줄기세포 및 이를 포함하는 면역질환의 예방 또는 치료용 세포치료제 조성물 | |
HUP9903679A2 (hu) | Olanzapin alkalmazása bipoláris zavar kezelésére szolgáló gyógyszerkészítmények előállítására | |
DE69433110D1 (de) | Allogenes vakzin und synthesemethode für selbiges | |
DK1231908T3 (da) | Farmaceutisk præparat, der omfatter en NO-donorforbindelse samt anvendelse heraf | |
MX2022011188A (es) | Derivado biciclico fusionado, metodo de preparacion y uso farmaceutico del mismo. | |
DE3878154D1 (de) | Oral anzuwendende arzneiform zur einmal taeglichen behandlung der hypertonie mit diltiazemhydrochlorid. | |
BR9815576A (pt) | Compostos substituìdos de difenil indanona, indana, e indola e análogos do mesmo, composição farmacêutica baseada nos referidos compostos, métodos de inbibição da proliferação célular em mamìferos e de tratamento ou prevenção de um distúrbio | |
Hubbard et al. | TISSUE FACTOR-FACTOR VII INHIBITION REQUIRES FACTOR Xa AND PLASMA LIPOPROTEINS. | |
DE60015306D1 (de) | Verwendung von beta interferon zur herstellung eines arzneimittels zur behandlung von ewings sarkom und eoe | |
Gilhar et al. | Ia expression in keratinocytes following ultraviolet radiation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EE | Request for examination | ||
EG | Technical examination (opinion): publication of technical examination (opinion) | ||
FC | Decision: refusal | ||
FC | Decision: refusal | ||
B15K | Others concerning applications: alteration of classification |
Ipc: A61K 31/715 (2006.01), A61K 31/7016 (2006.0 |